Yan H

ORCID: 0000-0002-7651-840X · 56 papers in corpus
2025
Frontiers in medicine ·doi:10.3389/fmed.2025.1563914

We present the case of a 39-year-old Chinese woman who presented with a palpable mass in her abdominal wall and pelvic cavity 9 years after undergoing laparoscopic myomectomy. Six abdominal wall fibroids, 18 intramural fibroids, 1 posterior…

article 2025
Cell genomics ·doi:10.1016/j.xgen.2024.100737

Endometriosis is a chronic condition with limited therapeutic options. The molecular aberrations promoting ectopic attachment and interactions with the local microenvironment sustaining lesion growth have been unclear, prohibiting developme…

article 2025
iScience ·doi:10.1016/j.isci.2025.114164

Endometriosis affects a substantial number of women of reproductive age, yet current diagnostic methods rely on invasive procedures. To address this limitation, we investigated THBS1 as a potential biomarker and regulator of disease progres…

meta-analysis 2025
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-025-01349-4

OBJECTIVE: To summarize evidence on the efficacy and safety of the levonorgestrel-releasing intrauterine system (LNG-IUS) in managing adenomyosis (AM), both as a monotherapy and in combination with other therapies. METHODS: We searched Med…

article 2025
BMC pregnancy and childbirth ·doi:10.1186/s12884-025-08513-z

BACKGROUND: Endometriosis affects approximately 10% of women of reproductive age and is associated with increased risks of infertility and miscarriage. Although the spontaneous miscarriage rate in women with endometriosis is higher than in …

other 2025
BMC women's health ·doi:10.1186/s12905-025-03997-5

OBJECTIVE: The malposition of the levonorgestrel-releasing intrauterine system (LNG-IUS) can have a considerable impact on the treatment outcomes for patients with adenomyosis. This study was designed to explore the relationship between the…

article 2024
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2024.104393

RESEARCH QUESTION: Are there correlations between the biological expression of steroid receptors and the extent of fibrosis in adenomyotic lesions, and the treatment effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS…

review 2024
Archives of gynecology and obstetrics ·doi:10.1007/s00404-024-07546-7

PURPOSE: To summarize evidence on levonorgestrel releasing intrauterine system (LNG-IUS) in the treatment of adenomyosis (AM) and to identify potential research gaps. METHODS: Search was conducted in MEDLINE, The Cochrane Library, EMBASE, …

article 2024
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2024.100349

PURPOSE: We aimed to examine the clinical characteristics of patients with ovarian endometriosis (OMA) who were diagnosed with recurrent pain after laparoscopic surgery in an 8- to 12- year postoperative follow-up. METHODS: We retrospectiv…

article 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1359649

BACKGROUND: The objective of our study was to investigate the risk factors for a decrease in ovarian reserve in patients with endometriomas after standardized laparoscopic procedures and evaluation to provide corresponding clinical guidance…

article 2024
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.16096

OBJECTIVE: This study aims to investigate the association between dietary intake of niacin and vitamin B6 and the prevalence of endometriosis using data from the National Health and Nutrition Examination Survey (NHANES) 2003-2006. METHODS:…

review 2024
Biology of reproduction ·doi:10.1093/biolre/ioae032

Endometriosis and adenomyosis are two similar gynecological diseases that are characterized by ectopic implantation and the growth of the endometrial tissue. Previous studies have reported that they share a common pathophysiology in some re…

2024
Medicine ·doi:10.1097/md.0000000000037428

RationaleUterine rupture during pregnancy poses significant risks to both the fetus and the mother, resulting in high mortality and morbidity rates. While awareness of uterine rupture prevention after a cesarean section has increased, insuf…

article 2023
Reproductive health ·doi:10.1186/s12978-023-01702-z

BACKGROUND: The aim of the study is to investigate the proportion and clinical features of previous spontaneously ruptured ovarian endometrioma among women who underwent elective surgery for endometrioma. METHODS: This retrospective study …

article 2023
Scientific reports ·doi:10.1038/s41598-023-40816-z

The purpose of this study was to implore the association among clinical features, long-term fertility outcomes and the anatomical location of adenomyosis identified by ultrasound. We collected data of non-pregnant patients between 20 and 40…

2023
EMBO molecular medicine ·doi:10.15252/emmm.202216373

The pathological retinal angiogenesis often causes blindness. Current anti-angiogenic therapy for proliferative retinopathy targets the vascular endothelial growth factor (VEGF), but many patients do not radically benefit from this therapy.…

review 2022
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2022.04.010

OBJECTIVE: We report a low-grade endometrial stromal sarcoma (ESS) with a novel CDKN1A-JAZF1 fusion gene arising from abdominal wall endometrioma. CASE REPORT: A 40-year-old woman presented with a 5.5-cm abdominal wall mass juxtaposed to t…

article 2022
Frontiers in medicine ·doi:10.3389/fmed.2022.905688

BACKGROUND: To examine and compare the differences in clinical characteristics and long-term postoperative outcomes of ovarian endometriomas (OMA) patients with and without dysmenorrhea, including data from at least 8 years of postoperative…

2022
Translational cancer research ·doi:10.21037/tcr-22-1180

BackgroundThere has been lack of guidance for stratify treatment between cervical endometrioid adenocarcinoma (EC) and ordinary cervical adenocarcinoma (AC), therefore understanding the difference of prognosis between EC and AC is important…

preprint 2022
·doi:10.22541/au.165276725.52323745/v1

Background: Adenomyosis (AM) is a common benign gynaecologic disease characterized by dysmenorrhea and heavy menstrual bleeding and requires for long-term management. Levonorgestrel - releasing Intrauterine System (LNG-IUS) is a long-acting…

other 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.08.856

OBJECTIVE: To review the use of oral gonadotropin-releasing hormone (GnRH) antagonists and synthesize their efficacy and safety parameters for the treatment of endometriosis-associated pain. DESIGN: Systematic review and network meta-analy…

2022
Medicine ·doi:10.1097/md.0000000000029928

The well-prepared endometrium with appropriate thickness plays a critical role in successful embryo implantation. The thin endometrium is the main factor of frozen-embryo transfer (FET), resulting in the failure of implantation undergoing F…

article 2022
Frontiers in medicine ·doi:10.3389/fmed.2022.872481

OBJECTIVE: This study aimed to establish an effective prognostic nomogram for the postoperative recurrence of endometrioma or endometriosis-related pain for patients with endometrioma after long-term follow-up, who were younger than 45 year…

article 2020
Experimental and therapeutic medicine ·doi:10.3892/etm.2020.8994

, can be traced back to the Song dynasty. Traditionally, SXS has been used to treat irregular menstruation, pelvic pain, progressive dysmenorrhea, and postpartum lochiorrhea. The management of adenomyosis (AM) is challenging and to the best…

2019
The Kaohsiung journal of medical sciences ·doi:10.1002/kjm2.12008

Polycystic ovary syndrome (PCOS) is a common female endocrine disorder that has a detriment impact on female health. Herein, the study used a case-control analysis to sought to explore the association of rs13405728, rs12478601, and rs247910…